Financing: What stops the successful formulation against cancer tests
One of the leaders of the research explains why even not can test it in humans. “We don't have the resources to do so”.
After testing in cells and animals, researchers at the University of Chile who managed to find an effective formulation based on turmeric that ended with an aggressive cancer metastasis, still can not test it in humans.
The reason? Financing.
In a conversation with Radio DNA, Felipe Oyarzun, academic and part of the Centre for advanced chronic diseases, ACCDiS , explained how Curcumin, applied after the removal of melanoma, completely inhibits its comeback, finishing with diseased cells without affecting healthy cells and precisely in the sector concerned.
“That does not occur when you have a normal anticancer therapy, such as chemotherapy or radiotherapy”. He told. “In this case what we are doing to the body, many times, It is to poison”, claiming that these treatments attack quickly multiplying cells, as the hair, stomach or even the heart.
What would fail to see its results in people? “The only problem we have is we have no resources to do so”, said.
In addition, details in Chile, the pharmaceutical industry has among its priorities the development of next-generation drugs and that the State, on the one hand supports the specialization but not research, because there are not enough jobs nor the funds and, While there are more specialists, rates for the award of projects is less, because the amounts do not increase.